Identification of endogenous 1‐aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation-Reference-Cited by-同舟云学术

Identification of endogenous 1‐aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation

Published:2020-05-28 Issue:15 Volume:177 Page:3415-3435
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Miao Hua¹,Cao Gang²,Wu Xia‐Qing¹,Chen Yuan‐Yuan¹,Chen Dan‐Qian¹,Chen Lin¹,Vaziri Nosratola D.³,Feng Ya‐Long¹,Su Wei⁴,Gao Yi⁵,Zhuang Shougang⁶^ORCID,Yu Xiao‐Yong⁷,Zhang Li⁸,Guo Yan⁹,Zhao Ying‐Yong¹^ORCID

Affiliation:

1. Faculty of Life Science & Medicine Northwest University Xi'an Shaanxi China

2. School of Pharmacy Zhejiang Chinese Medical University Hangzhou Zhejiang China

3. Division of Nephrology and Hypertension, School of Medicine University of California Irvine Irvine California USA

4. Department of Nephrology Baoji Central Hospital Baoji Shaanxi China

5. Department of Nephrology The Affiliated Hospital of Northwest University Xi'an Shaanxi China

6. Department of Medicine, Rhode Island Hospital and Alpert Medical School Brown University Providence Rhode Island USA

7. Department of Nephrology Shaanxi Traditional Chinese Medicine Hospital Xi'an Shaanxi China

8. Department of Nephrology Xi'an No. 4 Hospital Xi'an Shaanxi China

9. Department of Internal Medicine University of New Mexico Albuquerque New Mexico USA

Funder

National Natural Science Foundation of China

National Basic Research Program of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15062

Reference63 articles.

1. The Concise Guide to PHARMACOLOGY 2019/20: Enzymes;Alexander S. P. H.;British Journal of Pharmacology,2019

2. The Concise Guide To PHARMACOLOGY 2019/20: Introduction and other protein targets;Alexander S. P. H.;British Journal of Pharmacology,2019

3. Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

4. Modeling of the Aryl Hydrocarbon Receptor (AhR) Ligand Binding Domain and Its Utility in Virtual Ligand Screening to Predict New AhR Ligands

5. Lack of the aryl hydrocarbon receptor accelerates aging in mice

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation;Frontiers in Pharmacology;2024-08-22

2. Natural product pharmacology: the British Journal of Pharmacology perspective;British Journal of Pharmacology;2024-08-11

3. Targeting Lactobacillus johnsonii to reverse chronic kidney disease;Signal Transduction and Targeted Therapy;2024-08-05

4. Uremic toxins mediate kidney diseases: the role of aryl hydrocarbon receptor;Cellular & Molecular Biology Letters;2024-03-15

5. The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis;Frontiers in Pharmacology;2024-01-16